Choose a channel
Check out the different Progress in Mind content channels.
Progress in Mind
Dr Pablo Barrio, Spain talks about what to tell patients about their condition and discusses quality of life issues, treatment and more.
A. Patients aren’t told immediately although they are told they will have long-term treatment needs. It is left vague in order not to make it sound like a life sentence.
A. Yes. Patients are told they are likely to be on medication for 3 to 5 years. We usually try to present it as “at least three years”.
A. Symptom severity, especially negative symptoms, drug side-effects, family support and community resources all contribute to the quality of life of a patient with schizophrenia.
A. Medication is the psychiatrist’s responsibility and we need to balance efficacy with side-effects in order to ensure compliance with therapy. For other therapies, it depends on the resources available. A rehabilitation clinic would be made use of, if appropriate.
A. It’s both. There are genetic components with environmental triggers. It’s a multicomponent condition and it’s likely that schizophrenia comprises several diseases.
A. Optimistically, maybe 30%.
Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Otsuka and Lundbeck.